New Pediatric Cancer Leaders Named at NYU Langone Health
NYU Langone recruits two nationally recognized leaders in the field of pediatric cancer.
New Platform Tests Multiple Treatments Simultaneously
Dr. Diane M. Simeone, director of NYU Langone’s Pancreatic Cancer Center, discusses a new clinical trial platform for people with this disease.
New Program Aims to Stop Pancreatic Cancer Before It Starts
NYU Langone’s Dr. Diane Simeone launched a pancreatic cancer screening program for people at high risk, and a fellow physician benefited.
New Program Helps Clinicians Better Serve LGBTQ+ Patients
A unique data collection program at NYU Langone’s Perlmutter Cancer Center aims to help address healthcare disparities in LGBTQ+ communities.
New Rehabilitation Program Improves Cancer Survivors’ Lives
The Division of Oncological Rehabilitation at NYU Langone’s Rusk Rehabilitation helps re-establish optimal function in cancer survivors.
New Report Guides Pediatricians on Preventing Abuse of Child
Dr. Lori A. Legano, pediatrician at NYU Langone, sets out seven guidelines in new report for pediatricians to help prevent and recognize abuse.
New Requirements Impact Medicaid-Eligible Patients
The Family Health Centers at NYU Langone urges Medicare recipients to recertify and reenroll in the program to keep access to benefits.
New Research Sheds Light on COVID-19–Associated Stroke Risk
NYU Langone researchers launch a first-of-its-kind study examining evidence of ischemic stroke as a complication of COVID-19.
New Research Shows Dramatic Rise in Fentanyl Seizures
NYU Langone researchers report a dramatic increase in U.S. fentanyl seizures in the last six years, including pills containing the opioid drug.
New Role Found for Cell Mitochondria
NYU Langone researchers discover that mitochondria, the major energy source for most cells, also play an important role in stem cell development.